The first results concerning the prognostic value of angiogenic factors were reported in AML adult patients, showing that high levels of cellular VEGF were significantly correlated with shorter survival in patients with high WBC at diagnosis (P < 0.04), whereas no association was found with the plasma levels of bFGF [10]. This evidence concerns the gene VEGFA and acute myeloid leukemia.